DAA181 |
POU class 6 homeobox 1 |
Molecular |
brain |
Human |
POU6F1 |
4.0% Decrease Gene Expression Level |
|
DAA182 |
protein phosphatase 1E (PP2C domain containing) |
Molecular |
brain |
Human |
PPM1E |
17.0% Decrease Gene Expression Level |
|
DAA183 |
protein phosphatase 2 (formerly 2A), regulatory subunit A, alpha isoform |
Molecular |
brain |
Human |
PPP2R1A |
6.0% Decrease Gene Expression Level |
|
DAA184 |
protein phosphatase 5, catalytic subunit |
Molecular |
brain |
Human |
PPP5C |
7.0% Decrease Gene Expression Level |
|
DAA185 |
peroxiredoxin 6 |
Molecular |
brain |
Human |
PRDX6 |
11.0% Increase Gene Expression Level |
|
DAA186 |
protein kinase C, beta |
Molecular |
brain |
Human |
PRKCB |
11.0% Decrease Gene Expression Level |
|
DAA187 |
protein kinase C, gamma |
Molecular |
brain |
Human |
PRKCG |
12.0% Decrease Gene Expression Level |
|
DAA188 |
protein kinase C, zeta |
Molecular |
brain |
Human |
PRKCZ |
12.0% Decrease Gene Expression Level |
|
DAA189 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 8 |
Molecular |
brain |
Human |
PSMD8 |
8.0% Decrease Gene Expression Level |
|
DAA190 |
protein tyrosine phosphatase, receptor type, E |
Molecular |
brain |
Human |
PTPRE |
39.0% Decrease Gene Expression Level |
|
DAA191 |
poliovirus receptor-related 3 |
Molecular |
brain |
Human |
PVRL3 |
20.0% Decrease Gene Expression Level |
|
DAA192 |
quaking homolog, KH domain RNA binding (mouse) |
Molecular |
brain |
Human |
QKI |
8.0% Increase Gene Expression Level |
|
DAA193 |
RAB2A, member RAS oncogene family |
Molecular |
brain |
Human |
RAB2A |
11.0% Decrease Gene Expression Level |
|
DAA194 |
RAB3A, member RAS oncogene family |
Molecular |
brain |
Human |
RAB3A |
11.0% Decrease Gene Expression Level |
|
DAA195 |
v-ral simian leukemia viral oncogene homolog B (ras related; GTP binding protein) |
Molecular |
brain |
Human |
RALB |
7.0% Decrease Gene Expression Level |
|
DAA196 |
receptor (G protein-coupled) activity modifying protein 1 |
Molecular |
brain |
Human |
RAMP1 |
16.0% Increase Gene Expression Level |
|
DAA197 |
RAP2A, member of RAS oncogene family |
Molecular |
brain |
Human |
RAP2A |
28.0% Decrease Gene Expression Level |
|
DAA198 |
retinoic acid receptor responder (tazarotene induced) 2 |
Molecular |
brain |
Human |
RARRES2 |
9.0% Increase Gene Expression Level |
|
DAA199 |
Ras protein-specific guanine nucleotide-releasing factor 1 |
Molecular |
brain |
Human |
RASGRF1 |
22.0% Decrease Gene Expression Level |
|
DAA200 |
Ras association (RalGDS/AF-6) domain family member 2 |
Molecular |
brain |
Human |
RASSF2 |
18.0% Increase Gene Expression Level |
|
DAA201 |
retinoblastoma binding protein 5 |
Molecular |
brain |
Human |
RBBP5 |
9.0% Decrease Gene Expression Level |
|
DAA211 |
RNA binding motif protein 38 |
Molecular |
brain |
Human |
RBM38 |
12.0% Increase Gene Expression Level |
|
DAA202 |
retinol binding protein 4, plasma |
Molecular |
brain |
Human |
RBP4 |
13.0% Decrease Gene Expression Level |
|
DAA203 |
radixin |
Molecular |
brain |
Human |
RDX |
13.0% Increase Gene Expression Level |
|
DAA204 |
replication factor C (activator 1) 5, 36.5kDa |
Molecular |
brain |
Human |
RFC5 |
7.0% Decrease Gene Expression Level |
|